Applied BioCode Overview
- Year Founded
-
2008
- Status
-
Public
- Employees
-
43
- Stock Symbol
-
6598
- Share Price
-
$0.75
- (As of Friday Closing)
Applied BioCode General Information
Description
Applied BioCode Corp is engaged in designing, developing, manufacturing, and commercializing multiplex testing products for the in-vitro diagnostics market. The company's in-vitro diagnostic products focus on the molecular infectious disease segment of the market with assays that detect pathogens for gastrointestinal tract infections, respiratory infections, and sexually transmitted infections. The firm's products include barcoded magnetic bead technology (BMB). The BMB technology and detection systems assist in the development of multiplexed nucleic acids or protein detection assays. The company also develops applications for other areas of the diagnostics industry including life science research, agricultural testing, and veterinary markets.
Contact Information
Website
www.apbiocode.comCorporate Office
- 12130 Mora Drive
- Unit 2
- Santa Fe Springs, CA 90670
- United States
Corporate Office
- 12130 Mora Drive
- Unit 2
- Santa Fe Springs, CA 90670
- United States
Applied BioCode Stock Performance
As of 13-Nov-2026, Applied BioCode’s stock price is $0.75. Its current market cap is $77.3M with 103M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.75 | $0.75 | $0.65 - $0.98 | $77.3M | 103M | 215K | -$0.02 |
Applied BioCode Financials Summary
As of 30-Jun-2026, Applied BioCode has a trailing 12-month revenue of $21.5M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 58,402 | 54,550 | 36,511 | 45,883 |
| Revenue | 21,457 | 15,233 | 10,691 | 12,687 |
| EBITDA | (295) | (5,324) | (7,029) | (3,934) |
| Net Income | (1,574) | (6,450) | (8,127) | (5,272) |
| Total Assets | 33,651 | 32,382 | 36,945 | 32,323 |
| Total Debt | 1,609 | 1,904 | 594 | 1,121 |
Applied BioCode Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Applied BioCode Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Applied BioCode Comparisons
Industry
Financing
Details
Applied BioCode Competitors (26)
One of Applied BioCode’s 26 competitors is Meso Scale Diagnostics, a Corporation company based in Rockville, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Meso Scale Diagnostics | Corporation | Rockville, MD | ||||
| Correlia Biosystems | Venture Capital-Backed | Berkeley, CA | ||||
| Standard BioTools | Formerly VC-backed | Boston, MA | ||||
| Cell Biolabs | Corporation | San Diego, CA | ||||
| Preomics | Venture Capital-Backed | Munich, Germany |
Applied BioCode Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Applied BioCode Patents
Applied BioCode Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250102500-A1 | Process for high performance barcoded magnetic beads | Pending | 21-Sep-2023 | ||
| WO-2025064281-A1 | Process for high performance barcoded magnetic beads | Inactive | 21-Sep-2023 | ||
| EP-4728098-A1 | Method for dynamic range expansion for multiplex assays | Pending | 24-Jul-2023 | ||
| US-20250034629-A1 | Method for dynamic range expansion for multiplex assays | Pending | 24-Jul-2023 | ||
| WO-2025024151-A1 | Method for dynamic range expansion for multiplex assays | Inactive | 24-Jul-2023 | G01N33/54386 |
Applied BioCode Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Applied BioCode Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Applied BioCode ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Applied BioCode FAQs
-
When was Applied BioCode founded?
Applied BioCode was founded in 2008.
-
Where is Applied BioCode headquartered?
Applied BioCode is headquartered in Santa Fe Springs, CA.
-
What is the size of Applied BioCode?
Applied BioCode has 43 total employees.
-
What industry is Applied BioCode in?
Applied BioCode’s primary industry is Discovery Tools (Healthcare).
-
Is Applied BioCode a private or public company?
Applied BioCode is a Public company.
-
What is Applied BioCode’s stock symbol?
The ticker symbol for Applied BioCode is 6598.
-
What is the current stock price of Applied BioCode?
As of 13-Nov-2026 the stock price of Applied BioCode is $0.75.
-
What is the current market cap of Applied BioCode?
The current market capitalization of Applied BioCode is $77.3M.
-
What is Applied BioCode’s current revenue?
The trailing twelve month revenue for Applied BioCode is $21.5M.
-
Who are Applied BioCode’s competitors?
Meso Scale Diagnostics, Correlia Biosystems, Standard BioTools, Cell Biolabs, and Preomics are some of the 26 competitors of Applied BioCode.
-
What is Applied BioCode’s annual earnings per share (EPS)?
Applied BioCode’s EPS for 12 months was -$0.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
